首页> 美国卫生研究院文献>PLoS Clinical Trials >Resource use, costs, and approval times for planning and preparing a randomized clinical trial before and after the implementation of the new Swiss human research legislation
【2h】

Resource use, costs, and approval times for planning and preparing a randomized clinical trial before and after the implementation of the new Swiss human research legislation

机译:在实施新的瑞士人类研究法规之前和之后规划和准备随机临床试验的资源使用,成本和批准时间

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundThe preparation of a randomized controlled trial (RCT) requires substantial resources and the administrative processes can be burdensome. To facilitate the conduct of RCTs it is important to better understand cost drivers. In January 2014 the enactment of the new Swiss Legislation on Human Research (LHR) considerably changed the regulatory framework in Switzerland. We assess if the new LHR was associated with change in (i) resource use and costs to prepare an RCT, and (ii) approval times with research ethics committees (RECs) and the regulatory authority Swissmedic.
机译:背景技术随机对照试验(RCT)的准备需要大量资源,并且行政程序可能很繁重。为了促进进行RCT,重要的是要更好地了解成本动因。 2014年1月,新的《瑞士人类研究法》(LHR)的颁布大大改变了瑞士的监管框架。我们评估新的LHR是否与(i)准备RCT的资源使用和成本以及(ii)研究伦理委员会(RECs)和监管机构Swissmedic的批准时间有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号